Abstract
Tofacitinib is an FDA-approved compound for use in selected patients with rheumatoid arthritis. This agent has effects on T-cells, including interleukin (IL)-15, which has been demonstrated to be increased in lesional skin of psoriasis as well as in the outer root sheath in a mouse model of alopecia areata. These authors encountered a patient …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
